Powered by

-Xspray Pharma Has Carried out a Directed Share Issue Raising Gross Proceeds of Approximately SEK 265 million

Oct 21, 2020 - ENP Newswire
Mergers and Acquisitions

Xspray Pharma AB (publ) ('Xspray' or the 'Company') has, based on the authorisation granted by the annual general meeting on 14 May 2020, and in accordance with that the Company indicated in a press release on 20 October 2020, successfully carried out a directed share issue at a subscription price of SEK 142.50 per share (the 'Issue').

The subscription price has been determined through an accelerated bookbuild transaction.

A number of Swedish and international institutional in...